FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2983069922> ?p ?o ?g. }

• W2983069922 endingPage "194" @default.
• W2983069922 startingPage "186" @default.
• W2983069922 abstract "BACKGROUND The rapid adoption and widespread use of direct oral anticoagulants (DOACs) has outpaced research efforts to establish their effects in bleeding trauma patients. In patients with complicated traumatic brain injury (TBI) caused by intracranial hemorrhage, DOAC use may be associated with higher bleeding volume and potentially more disastrous sequelae than use of vitamin K antagonists (VKAs). In the current systematic review and meta-analysis we set out to evaluate the literature on the relationship between preinjury DOAC use and course of the intracranial hemorrhage. (ICH), its treatment and mortality rates in TBI patients, and to compare these outcomes to those of patients with preinjury VKA use. METHODS PubMed, Embase, Web of Science, and the Cochrane Library were searched using a search strategy including three main terms: “traumatic brain injury,” “direct oral anticoagulants,” and “vitamin K antagonists.” There were 1,446 abstracts screened, and ultimately, six included articles. Random effects modeling meta-analysis was performed on in-hospital mortality, ICH progression and neurosurgical intervention rate. RESULTS All cohorts had similar baseline and emergency department parameters. Within individual studies surgery rate, reversal agents used, ICH progression and in-hospital mortality differed significantly between DOAC and VKA cohorts. Meta-analysis showed no significant difference in in-hospital mortality (odds ratio [OR], 0.98; 95% confidence interval [CI], 0.23–4.06; I 2 = 76%; p = 0.97), neurosurgical interventions (OR, 0.48; 95% CI, 0.14–1.63; p = 0.24), or ICH progression rates (OR, 1.86; 95% CI, 0.32–10.66; p = 0.49) between patients that used preinjury DOACs versus patients that used VKAs. CONCLUSION Direct oral anticoagulant-using mild TBI patients do not appear to be at an increased risk of in-hospital mortality, nor of increased ICH progression or surgery rates, compared with those taking VKAs. LEVEL OF EVIDENCE Systematic review, level III." @default.
• W2983069922 created "2019-11-22" @default.
• W2983069922 creator A5011963351 @default.
• W2983069922 creator A5026613773 @default.
• W2983069922 creator A5029896762 @default.
• W2983069922 creator A5034037597 @default.
• W2983069922 creator A5052979025 @default.
• W2983069922 creator A5066083221 @default.
• W2983069922 creator A5080314023 @default.
• W2983069922 date "2019-10-30" @default.
• W2983069922 modified "2023-10-13" @default.
• W2983069922 title "Consequences of pre-injury utilization of direct oral anticoagulants in patients with traumatic brain injury: A systematic review and meta-analysis" @default.
• W2983069922 cites W1581215160 @default.
• W2983069922 cites W1898921310 @default.
• W2983069922 cites W1977702253 @default.
• W2983069922 cites W2007872832 @default.
• W2983069922 cites W2017044005 @default.
• W2983069922 cites W2061975416 @default.
• W2983069922 cites W2063976695 @default.
• W2983069922 cites W2095060228 @default.
• W2983069922 cites W2107328434 @default.
• W2983069922 cites W2125348945 @default.
• W2983069922 cites W2132626412 @default.
• W2983069922 cites W2139912660 @default.
• W2983069922 cites W2158143297 @default.
• W2983069922 cites W2294389396 @default.
• W2983069922 cites W2444421764 @default.
• W2983069922 cites W2460170655 @default.
• W2983069922 cites W2471094169 @default.
• W2983069922 cites W2496155895 @default.
• W2983069922 cites W2507928108 @default.
• W2983069922 cites W2514335032 @default.
• W2983069922 cites W2532812314 @default.
• W2983069922 cites W2598370951 @default.
• W2983069922 cites W2598460446 @default.
• W2983069922 cites W2604343378 @default.
• W2983069922 cites W2604517925 @default.
• W2983069922 cites W2604738434 @default.
• W2983069922 cites W2615225192 @default.
• W2983069922 cites W2736956220 @default.
• W2983069922 cites W2749566272 @default.
• W2983069922 cites W2762057594 @default.
• W2983069922 cites W2786586881 @default.
• W2983069922 cites W2793926437 @default.
• W2983069922 cites W2794798533 @default.
• W2983069922 cites W2804806966 @default.
• W2983069922 cites W2806615369 @default.
• W2983069922 cites W2810316516 @default.
• W2983069922 cites W2886509534 @default.
• W2983069922 cites W2898894985 @default.
• W2983069922 cites W2902046728 @default.
• W2983069922 doi "https://doi.org/10.1097/ta.0000000000002518" @default.
• W2983069922 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31688828" @default.
• W2983069922 hasPublicationYear "2019" @default.
• W2983069922 type Work @default.
• W2983069922 sameAs 2983069922 @default.
• W2983069922 citedByCount "18" @default.
• W2983069922 countsByYear W29830699222020 @default.
• W2983069922 countsByYear W29830699222021 @default.
• W2983069922 countsByYear W29830699222022 @default.
• W2983069922 countsByYear W29830699222023 @default.
• W2983069922 crossrefType "journal-article" @default.
• W2983069922 hasAuthorship W2983069922A5011963351 @default.
• W2983069922 hasAuthorship W2983069922A5026613773 @default.
• W2983069922 hasAuthorship W2983069922A5029896762 @default.
• W2983069922 hasAuthorship W2983069922A5034037597 @default.
• W2983069922 hasAuthorship W2983069922A5052979025 @default.
• W2983069922 hasAuthorship W2983069922A5066083221 @default.
• W2983069922 hasAuthorship W2983069922A5080314023 @default.
• W2983069922 hasConcept C118552586 @default.
• W2983069922 hasConcept C126322002 @default.
• W2983069922 hasConcept C156957248 @default.
• W2983069922 hasConcept C179755657 @default.
• W2983069922 hasConcept C2776478404 @default.
• W2983069922 hasConcept C2781017439 @default.
• W2983069922 hasConcept C44249647 @default.
• W2983069922 hasConcept C71924100 @default.
• W2983069922 hasConcept C95190672 @default.
• W2983069922 hasConceptScore W2983069922C118552586 @default.
• W2983069922 hasConceptScore W2983069922C126322002 @default.
• W2983069922 hasConceptScore W2983069922C156957248 @default.
• W2983069922 hasConceptScore W2983069922C179755657 @default.
• W2983069922 hasConceptScore W2983069922C2776478404 @default.
• W2983069922 hasConceptScore W2983069922C2781017439 @default.
• W2983069922 hasConceptScore W2983069922C44249647 @default.
• W2983069922 hasConceptScore W2983069922C71924100 @default.
• W2983069922 hasConceptScore W2983069922C95190672 @default.
• W2983069922 hasIssue "1" @default.
• W2983069922 hasLocation W29830699221 @default.
• W2983069922 hasOpenAccess W2983069922 @default.
• W2983069922 hasPrimaryLocation W29830699221 @default.
• W2983069922 hasRelatedWork W2189666756 @default.
• W2983069922 hasRelatedWork W2286371484 @default.
• W2983069922 hasRelatedWork W2724674370 @default.
• W2983069922 hasRelatedWork W2747457586 @default.
• W2983069922 hasRelatedWork W3184554080 @default.
• W2983069922 hasRelatedWork W3206692032 @default.
• W2983069922 hasRelatedWork W4232204633 @default.

• next